Switch to:
Amgen Inc  (NAS:AMGN) Net Cash per Share: \$-11.82 (As of Jun. 2017)

Net cash per share is calculated as Cash And Cash Equivalents minus Total Liabilities and then divided by Shares Outstanding (Diluted Average). Amgen Inc's net cash per share for the quarter that ended in Jun. 2017 was \$-11.82.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Amgen Inc Annual Data

 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Net Cash per Share 0.00 0.00 0.00 0.00 0.00

Amgen Inc Quarterly Data

 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Net Cash per Share 0.00 0.00 0.00 0.00 0.00

Calculation

In the calculation of a company's net cash, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative net cash. But sometimes a company's price may be lower than its net-cash.

Amgen Inc's Net Cash Per Share for the fiscal year that ended in Dec. 2016 is calculated as

 Net Cash Per Share (A: Dec. 2016 ) = (Cash And Cash Equivalents - Total Liabilities) / Shares Outstanding (Diluted Average) = (38085 - 47751) / 738.20 = -13.09

Amgen Inc's Net Cash Per Share for the quarter that ended in Jun. 2017 is calculated as

 Net Cash Per Share (Q: Jun. 2017 ) = (Cash And Cash Equivalents - Total Liabilities) / Shares Outstanding (Diluted Average) = (39227 - 47865) / 731.00 = -11.82

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener. GuruFocus also publishes a monthly Net-Net newsletter.

Related Terms

From the Internet

###### Value System Amgen Looks Undervalued

- Seekingalpha 2017-10-17 23:03:53

###### Delta Air Lines, BioTelemetry, TransUnion: 'Mad Money' Lightning Round

- theStreet 2017-10-17 21:27:00

###### ImmunoGen to Push Leukemia Candidate into Phase I Trial

- Zacks 2017-10-17 16:55:00

###### Medicines Company May Best Investment 2017

- Seekingalpha 2017-10-17 16:10:43

###### Johnson & Johnson says recent hurricane activity had ‘modest’ effect on company

- MarketWatch 2017-10-17 11:50:00

###### Real Dividend Growth Machine Q3 2017 Portfolio Review

- Seekingalpha 2017-10-17 10:46:03

###### Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen

- Zacks 2017-10-17 08:44:00

###### Records for Wall Street as Apple Gains Offset Healthcare Slide

- theStreet 2017-10-16 16:12:00

###### Pharma Industry Outlook - October 2017

- Zacks 2017-10-16 14:59:00

###### Daily Pharma Scoop Acrx Second Chance Aeri Rhopressa Success Aratana Entyce Launch

- Seekingalpha 2017-10-16 13:00:32

###### Johnson & Johnson earnings: All eyes on hurricane impact

- MarketWatch 2017-10-16 11:18:00

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)